CHPA Agenda 2014: Monograph Reform, NSURE Progress
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association plans to tackle big tasks in 2014, including working with FDA to improve the monograph system, move the new Rx-to-OTC switch paradigm forward and determine quality metrics to help FDA better target inspections. The trade group also is looking for ways to ease pricing pressures and ensure quality does not suffer.
You may also be interested in...
In Brief: Helen Of Troy In Supplements; J&J Innovation; U.K. Ad Enforcement; CHPA Chairman-elect; Hispanic Consumer Health
Helen Of Troy Acquires Supplement Firm; J&J eyes probiotics to skin, oral health and respiratory conditions; ASA rules on Danon Baby Nutrition ad; FDA continues to pursue tainted supplements; FDA warns about tainted bee pollen; CHPA names board chair-elect; and USP educates Hispanics about supplements.
In Brief: Helen Of Troy In Supplements; J&J Innovation; U.K. Ad Enforcement; CHPA Chairman-elect; Hispanic Consumer Health
Helen Of Troy Acquires Supplement Firm; J&J eyes probiotics to skin, oral health and respiratory conditions; ASA rules on Danon Baby Nutrition ad; FDA continues to pursue tainted supplements; FDA warns about tainted bee pollen; CHPA names board chair-elect; and USP educates Hispanics about supplements.
House Pushes FDA To Expedite Sunscreen Ingredient Reviews
Reps. Dingell and Whitfield ask for FDA’s assistance on legislation they are writing to expedite the agency’s review of additional sunscreen ingredients. CDER Director Woodcock pledges FDA help, but explains the agency’s OTC ingredient reviews are “backlogged.”